JP2024528731A5 - - Google Patents
Info
- Publication number
- JP2024528731A5 JP2024528731A5 JP2024505211A JP2024505211A JP2024528731A5 JP 2024528731 A5 JP2024528731 A5 JP 2024528731A5 JP 2024505211 A JP2024505211 A JP 2024505211A JP 2024505211 A JP2024505211 A JP 2024505211A JP 2024528731 A5 JP2024528731 A5 JP 2024528731A5
- Authority
- JP
- Japan
- Prior art keywords
- day
- ibudilast
- composition according
- administered
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163225820P | 2021-07-26 | 2021-07-26 | |
| US63/225,820 | 2021-07-26 | ||
| PCT/US2022/038157 WO2023009425A1 (en) | 2021-07-26 | 2022-07-25 | Ibudilast for preventing eye cancer metastasis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024528731A JP2024528731A (ja) | 2024-07-30 |
| JP2024528731A5 true JP2024528731A5 (enExample) | 2025-07-31 |
Family
ID=82851760
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024505211A Pending JP2024528731A (ja) | 2021-07-26 | 2022-07-25 | 眼癌転移を予防するためのイブジラスト |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US12005049B2 (enExample) |
| EP (1) | EP4376838B1 (enExample) |
| JP (1) | JP2024528731A (enExample) |
| CN (1) | CN117940128A (enExample) |
| CA (1) | CA3226898A1 (enExample) |
| WO (1) | WO2023009425A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2024528731A (ja) | 2021-07-26 | 2024-07-30 | メディシノバ・インコーポレイテッド | 眼癌転移を予防するためのイブジラスト |
| US12042485B2 (en) | 2021-10-07 | 2024-07-23 | Medicinova, Inc. | Methods of minimizing cancer metastasis |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU8562198A (en) | 1998-08-10 | 2000-03-06 | Kyorin Pharmaceutical Co. Ltd. | Remedies for multiple sclerosis |
| WO2006063048A2 (en) | 2004-12-06 | 2006-06-15 | Avigen, Inc. | Ibudilast for treating neuropathic pain and associated syndromes |
| CA2693697C (en) | 2007-07-11 | 2017-07-25 | Medicinova, Inc. | Treatment of progressive neurodegenerative disease with ibudilast |
| US20150157584A1 (en) * | 2012-06-11 | 2015-06-11 | The J. David Gladstone Institutes | Inhibitors of hippo-yap signaling pathway |
| US10258611B2 (en) | 2014-11-26 | 2019-04-16 | Medicinova, Inc. | Combination of ibudilast and riluzole and methods of using same |
| EP3558301A4 (en) | 2016-12-22 | 2020-07-29 | MediciNova, Inc. | METHOD FOR TREATING GLIOBLASTOMA MULTIFORME WITH IBUDILAST |
| CA3090884A1 (en) | 2018-02-12 | 2019-08-15 | Medicinova, Inc. | Methods and dosing regimens using ibudilast and a second agent for cancer therapy |
| CA3090887A1 (en) | 2018-02-12 | 2019-08-15 | Medicinova, Inc. | Methods of suppressing myeloid-derived suppressor cells in patients |
| EP3863628B1 (en) | 2018-10-09 | 2023-12-27 | MediciNova, Inc. | Combination of ibudilast and interferon-beta and methods of using same |
| ES2970996T3 (es) | 2018-10-19 | 2024-06-03 | Medicinova Inc | Tratamiento de la lesión macular asociada a la esclerosis múltiple con ibudilast |
| JP7652763B2 (ja) | 2019-09-23 | 2025-03-27 | メディシノバ・インコーポレイテッド | イブジラスト経口製剤およびその使用方法 |
| CN115335049A (zh) | 2020-04-06 | 2022-11-11 | 美迪诺亚公司 | 降低患者中巨噬细胞迁移抑制因子的血浆水平的方法 |
| CN116887829A (zh) | 2021-01-29 | 2023-10-13 | 美迪诺亚公司 | 治疗化学气体暴露的方法 |
| JP2024528731A (ja) | 2021-07-26 | 2024-07-30 | メディシノバ・インコーポレイテッド | 眼癌転移を予防するためのイブジラスト |
| CA3231869A1 (en) | 2021-09-21 | 2023-03-30 | Medicinova, Inc. | Ibudilast in combination therapy for use in the treatment of glioblastoma |
| US12042485B2 (en) | 2021-10-07 | 2024-07-23 | Medicinova, Inc. | Methods of minimizing cancer metastasis |
| JP2025504984A (ja) | 2022-02-01 | 2025-02-19 | メディシノバ・インコーポレイテッド | Ｃｏｖｉｄ後症状の治療における使用のためのイブジラスト |
-
2022
- 2022-07-25 JP JP2024505211A patent/JP2024528731A/ja active Pending
- 2022-07-25 US US17/872,855 patent/US12005049B2/en active Active
- 2022-07-25 CN CN202280059689.8A patent/CN117940128A/zh active Pending
- 2022-07-25 EP EP22754252.9A patent/EP4376838B1/en active Active
- 2022-07-25 CA CA3226898A patent/CA3226898A1/en active Pending
- 2022-07-25 WO PCT/US2022/038157 patent/WO2023009425A1/en not_active Ceased